Why Outsourcing to a Drug Discovery Incubator Makes Sense

Posted by Integral BioScience on November 25th, 2020

Pharmaceutical companies are increasingly outsourcing research to other organizations. Assigning a drug discovery incubator the task of doing the groundwork for formulating a new treatment is a growing trend. More and more biopharmaceutical companies are partnering with research organizations on drug discovery projects. Why are large corporations that have dedicated research departments relying on other organizations for the purpose? There are various factors that encourage pharmacy majors to join hands with professional drug discovery services. Here we are listing the major reasons why pharmaceutical enterprises are using external assistance for research.

1. Reduce the Costs of Drug Development

Discovering and developing new and better therapeutics is a cost-intensive process. A study suggests that the global pharma industry spends more than billion on launching a new drug in the market. Many times, drug candidates fail at the last stage of the process causing massive losses to the organizations involved in the development. There are concerns among the companies about diminishing economic returns. Delegating the initial research to external drug discovery laboratories makes better sense as such agencies have the capacity to devious better in vitro and in vivo methods. This helps companies save money that they would have had to spend on making the in-house arrangements.

2. Access to Specialists and Modern Technologies

Another reason why the trend has gathered pace is that a drug discovery incubator has dedicated specialists and cutting edge technology. The advancements made in the fields of high-throughput screening and combinatorial chemistry have helped in the identification of better lead molecules and targets. It is difficult for all companies to create the necessary infrastructure and hire experts with great expertise in the domain. Partnering with drug discovery services gives them access to specialists and sophisticated technologies without incurring prohibitive costs.

3. Accelerate the Drug Development Process

The initial stages of a drug discovery process rarely give a hint about the project’s success or failure. There is always a chance of sustaining losses if the findings are not promising. A failed project and the subsequent losses can affect the other work being done by an organization. When the process is outsourced to external drug discovery laboratories, it helps in mitigating the risks involved in the research. The pharma company can handle the major functions while the specialist agency conducts all the processes involved in the research.

Contact Integral BioSciences- An Efficient Drug Discovery Incubator to Outsource Your Projects

Integral BioSciences works with major biopharmaceutical companies in the field of small molecule drug discovery. It enjoys the reputation of providing efficient drug discovery services to all its clients. Think strategically and reduce your risks by partnering with Integral BioSciences.

Like it? Share it!


Integral BioScience

About the Author

Integral BioScience
Joined: November 25th, 2020
Articles Posted: 1